KTTAW
Financials
- Market Capitalization 250.6084 K
- Employee 5
- Founded 2020
- CEO N/A
- Website www.pasithea.com
- Headquarter Delaware, United States
- FIGI BBG01231TZF3
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5089 |  CDT CDT Equity Inc. - Common Stock | 1.69 USD | -10.11% | -42.71% | -34.75% | +26.12% | 1.33 M USD | ||
| 5100 |  SCNI Scinai Immunotherapeutics Ltd - American Depositary Shares | 2.51 USD | -6.34% | -22.77% | +865.38% | +231.92% | 870.52 K USD | ||
| 5155 |  BDRX Biodexa Pharmaceuticals plc - American Depositary Shares | 0.87 USD | -3.33% | -30.40% | -31.50% | -37.86% | 78.58 K USD | ||
| 5164 |  CMND Clearmind Medicine Inc. - Common Shares | 1.77 USD | -2.21% | +2.91% | +20.41% | +68.57% | 27.98 K USD |
Frequently asked questions about Pasithea Therapeutics Corp. Warrants
What is the Pasithea Therapeutics Corp. Warrants stock price today?
The current price of Pasithea Therapeutics Corp. Warrants (KTTAW) is 0.0075. Over the past 24 hours, the stock has changed by +25.33%. Follow the KTTAW chart for real-time price dynamics.
What is the stock ticker of Pasithea Therapeutics Corp. Warrants?
Pasithea Therapeutics Corp. Warrants trades under the ticker KTTAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pasithea Therapeutics Corp. Warrants stock going up?
KTTAW has changed by +47.06% over the last week, +36.36% over the last month, and -54.55% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Pasithea Therapeutics Corp. Warrants?
Pasithea Therapeutics Corp. Warrants currently has a market capitalization of 250.61 K. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Pasithea Therapeutics Corp. Warrants earnings last quarter?
Last quarter, Pasithea Therapeutics Corp. Warrants reported earnings of -0.16 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Pasithea Therapeutics Corp. Warrants revenue for the last quarter?
Pasithea Therapeutics Corp. Warrants reported quarterly revenue of -29.79 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Pasithea Therapeutics Corp. Warrants net income for the last quarter?
Pasithea Therapeutics Corp. Warrants reported net income of -5.27 M for the last quarter. The previous quarter showed -2.87 M, which means net income changed by -83.79%.
How many employees does Pasithea Therapeutics Corp. Warrants have?
As of the latest available data, Pasithea Therapeutics Corp. Warrants has 5 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pasithea Therapeutics Corp. Warrants EBITDA?
Pasithea Therapeutics Corp. Warrants EBITDA is -1.9 M, and its EBITDA margin is 6 377.27%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pasithea Therapeutics Corp. Warrants stock?
You can buy Pasithea Therapeutics Corp. Warrants (KTTAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pasithea Therapeutics Corp. Warrants stock?
Investing in Pasithea Therapeutics Corp. Warrants requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KTTAW chart and related analysis on metatrader.com as part of your research.